Predicting the future in peripartum cardiomyopathy

Heart

Volumn 99, Issue 5, 2012, Pages 295-296

  Pieper, Petronella G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA; UTERUS SPASMOLYTIC AGENT;

AGE; BODY MASS; ECHOCARDIOGRAPHY; EDITORIAL; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; IMMUNE RESPONSE; INCIDENCE; MORTALITY; MULTIPLE PREGNANCY; PARITY; PATHOGENESIS; PERIPARTUM CARDIOMYOPATHY; PREDICTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RACE; RISK FACTOR; SOCIOECONOMICS; TH1 TH2 BALANCE; VIRUS INFECTION;

CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; PERIPARTUM PERIOD; VENTRICULAR FUNCTION, LEFT;

EID: 84874108789     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-303124     Document Type: Editorial

References (15)

1. Ritchie C. Clinical contribution to the pathology, diagnosis and treatment of certain chronic diseases in the heart. Edinburgh Med Surg J 1849; 2:333.
2. Karaye KM, Henein MY. Peripartum cardiomyopathy: a review article. Int J Card 2011. http://dx.doi.org/10.1016/j.ijcard.2011.11.069 (accessed 20 Dec 2011).
3. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010; 12: 767-78.
4. Fett JD, McTiernan CF. Towards a unifying hypothesis for the pathogenesis of peripartum cardiomyopathy. Int J Card 2011; 153:1-3.
5. Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States. J Am Coll Card 2011; 58:659-70.
6. Biteker M, Ilhan E, Biteker G, et al. Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow up and sustained therapy. Eur J Heart Fail 2012; 14:895-901.
7. Goland S, Bitar F, Modi K, et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Cardiac Fail 2011; 17:426-30.
8. Blauwet LA, Libhaber E, Forster O, et al. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart 2013; 99:308-13.
9. Morse SA, Gulati R, Reisin E. The obesity paradox and cardiovascular disease. Curr Hypert Rep 2010; 12:1201-126.
10. Karaye KM, Sani MU. The impact of income on the echocardiographic pattern of heart diseases in Kano, Nigeria. Niger J Med 2008; 17:350-5.
11. Sliwa K, Skudicky D, Candy G, et al. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 2002; 4:305-9.
12. Horwich T. Low-density Lipoprotein in the setting of congestive heart failure: is lower really better? Curr Atheroscler Rep 2009; 11:343-9.
13. Sharma R, Von Haeling S, Rauchhaus M, et al. Whole blood endoxin responsiveness in patients with chornic heart failure: the importance of serum lipoproteins. Eur J Heart Fail 2005; 7: 479-84.
14. Yoon C, Youn T, Ahn S, et al. Low serum total cholesterol level is a surrogate marker, but not a risk factor, for poor outcome in patients hospitalized with acute heart failure: a report from the Korean Heart Failure Registry. J Card Fail 2012; 18: 194-201.
15. Sliwa K, Blauwet L, Tibarzawa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010; 121:1465-73.